Evolving Use of Real-World Evidence for Devices: Good for Patients, Good for Policy Makers

被引：3
|
作者：
Mullins, C. Daniel [1 ]
机构：
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA
来源：
VALUE IN HEALTH | 2019年 / 22卷 / 07期
关键词：
TASK-FORCE;
D O I：
10.1016/j.jval.2019.04.1923
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：751 / 753
页数：3
相关论文
共 50 条
  • [31] The use of real-world evidence in European medicines regulation
    Brown, Jeremy P.
    Wing, Kevin
    Evans, Stephen
    Bhaskaran, Krishnan
    Smeeth, Liam
    Douglas, Ian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 205 - 206
  • [32] Use of real-world evidence in translational pharmacology research
    Charveriat, Mathieu
    Darmoni, Stephan J.
    Lafon, Vincent
    Moore, Nicholas
    Bordet, Regis
    Veys, Julien
    Mouthon, Franck
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 (02) : 230 - 236
  • [33] The use of real-world data/evidence in regulatory submissions
    Song, Fuyu
    Zang, Chenxuan
    Ma, Xinyi
    Hu, Sifan
    Sun, Qiqing
    Chow, Shein-Chung
    Sun, Hongqiang
    CONTEMPORARY CLINICAL TRIALS, 2021, 109
  • [34] Examining the Use of Real-World Evidence in the Regulatory Process
    Beaulieu-Jones, Brett K.
    Finlayson, Samuel G.
    Yuan, William
    Altman, Russ B.
    Kohane, Isaac S.
    Prasad, Vinay
    Yu, Kun-Hsing
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 843 - 852
  • [35] Is Decentralization Good for Development?: Perspectives from Academics and Policy Makers
    Eaton, Kent
    PERSPECTIVES ON POLITICS, 2016, 14 (03) : 898 - 900
  • [36] Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
    Chen, Jie
    Gruber, Susan
    Lee, Hana
    Chu, Haitao
    Lee, Shiowjen
    Tian, Haijun
    Wang, Yan
    He, Weili
    Jemielita, Thomas
    Song, Yang
    Tamura, Roy
    Tian, Lu
    Zhao, Yihua
    Chen, Yong
    van Der Laan, Mark
    Nie, Lei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (04) : 946 - 960
  • [37] Evidence and timing: The keys to good policy
    Colman, Colette
    AUSTRALIAN JOURNAL OF RURAL HEALTH, 2021, 29 (06) : 1009 - 1010
  • [38] The 'good governance' of evidence in health policy
    Hawkins, Benjamin
    Parkhurst, Justin
    EVIDENCE & POLICY, 2016, 12 (04): : 575 - 592
  • [39] Is Good Enough Good Enough? E-Cigarettes, Evidence, and Policy
    Fairchild, Amy Lauren
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2021, 111 (02) : 221 - 223
  • [40] A FRAMEWORK FOR CONDUCTING PROBABILISTIC SENSITIVITY ANALYSIS (PSA) WHEN MODELING WITH REAL-WORLD EVIDENCE (RWE) - HOW GOOD IS THE GUIDANCE?
    Ramjee, L.
    Tremblay, G.
    VALUE IN HEALTH, 2020, 23 : S291 - S291
12345